Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass

[1]  L. Genser,et al.  Bariatric surgery versus intensive medical therapy for diabetes -5- year outcomes , 2017 .

[2]  B. Wolfe,et al.  Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study , 2016, Diabetes Care.

[3]  J. Holst,et al.  Preoperative β‐cell function in patients with type 2 diabetes is important for the outcome of Roux‐en‐Y gastric bypass surgery , 2015, The Journal of physiology.

[4]  J. Holst,et al.  Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass. , 2015, American journal of physiology. Endocrinology and metabolism.

[5]  E. Chambers,et al.  Coinfusion of Low-Dose GLP-1 and Glucagon in Man Results in a Reduction in Food Intake , 2014, Diabetes.

[6]  C. Bouchard,et al.  Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. , 2014, JAMA.

[7]  C. Ling,et al.  β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment , 2014, Diabetes Care.

[8]  Claudio Cobelli,et al.  The Oral Minimal Model Method , 2014, Diabetes.

[9]  A. Carpentier,et al.  Limited Recovery of β-Cell Function After Gastric Bypass Despite Clinical Diabetes Remission , 2014, Diabetes.

[10]  A. Gastaldelli,et al.  Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  Luis Garcia,et al.  Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. , 2013, JAMA.

[12]  J. Holst,et al.  Long-Term Effects of Bariatric Surgery on Meal Disposal and β-Cell Function in Diabetic and Nondiabetic Patients , 2013, Diabetes.

[13]  M. Anselmino,et al.  Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. , 2013, The Journal of clinical endocrinology and metabolism.

[14]  S. Klein,et al.  Gastric bypass and banding equally improve insulin sensitivity and β cell function. , 2012, The Journal of clinical investigation.

[15]  J. Holst,et al.  Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. , 2012, American journal of physiology. Endocrinology and metabolism.

[16]  Yaniv Harel,et al.  Accelerated Gastric Emptying but No Carbohydrate Malabsorption 1 Year After Gastric Bypass Surgery (GBP) , 2012, Obesity Surgery.

[17]  B. Van der Schueren,et al.  Magnitude and Variability of the Glucagon-Like Peptide-1 Response in Patients With Type 2 Diabetes up to 2 Years Following Gastric Bypass Surgery , 2011, Diabetes Care.

[18]  D. D’Alessio,et al.  Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans , 2011, Diabetes.

[19]  M. Anselmino,et al.  The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. , 2011, The Journal of clinical endocrinology and metabolism.

[20]  A. Mari,et al.  Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes , 2011, Diabetologia.

[21]  J. Holst,et al.  The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action , 2010, Diabetes.

[22]  I. Hirsch,et al.  Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications. , 2010, JAMA.

[23]  Sonia Caprio,et al.  How Do We Define Cure of Diabetes? , 2009, Diabetes Care.

[24]  M. Schambelan,et al.  Improvement in Peripheral Glucose Uptake After Gastric Bypass Surgery Is Observed Only After Substantial Weight Loss Has Occurred and Correlates with the Magnitude of Weight Lost , 2009, Journal of Gastrointestinal Surgery.

[25]  B. Wolfe,et al.  Perioperative safety in the longitudinal assessment of bariatric surgery. , 2009, The New England journal of medicine.

[26]  M. Bessler,et al.  Prospective Study of Gut Hormone and Metabolic Changes After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass , 2009, International Journal of Obesity.

[27]  S. Salinari,et al.  First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric Surgery , 2009, Diabetes Care.

[28]  M. Suter,et al.  Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release , 2008, Obesity.

[29]  Daniel B. Jones,et al.  Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. , 2007, The Journal of clinical endocrinology and metabolism.

[30]  M. Sundbom,et al.  Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[31]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[32]  B. Wolfe,et al.  Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[33]  A. Mari,et al.  Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.

[34]  Claudio Cobelli,et al.  Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. , 2005, Diabetes.

[35]  Michael Horowitz,et al.  Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. , 2005, American journal of physiology. Endocrinology and metabolism.

[36]  T. Alexandrides,et al.  Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. , 2003, Diabetes.

[37]  B. Ahrén,et al.  Improved beta-cell function after standardized weight reduction in severely obese subjects. , 2003, American journal of physiology. Endocrinology and metabolism.

[38]  S. Kahn,et al.  The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .

[39]  S E Kahn,et al.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. , 1996, The Journal of clinical investigation.

[40]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[41]  G. Dohm,et al.  Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. , 1992, The American journal of clinical nutrition.

[42]  A. Permutt,et al.  Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. , 1982, Surgery.

[43]  R. Holman,et al.  Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. , 1976, British medical journal.

[44]  Mary Lisa Pories,et al.  Following Bariatric Surgery: an Exploration of the Couples’ Experience , 2015, Obesity Surgery.

[45]  M. Schambelan,et al.  Changes in Postprandial Glucose and Pancreatic Hormones , and Steady-State Insulin and Free Fatty Acids after Gastric Bypass Surgery , 2014 .

[46]  M. Schambelan,et al.  Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[47]  M. Anselmino,et al.  The Role of (cid:1) -Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery , 2011 .

[48]  A. Patriti,et al.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. , 2007, Annals of surgery.

[49]  J. Holst,et al.  Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. , 1993, The Journal of clinical investigation.